ANI Pharmaceuticals Q1 2025 Filing

Ticker: ANIP · Form: 10-Q · Filed: May 9, 2025 · CIK: 1023024

Ani Pharmaceuticals Inc 10-Q Filing Summary
FieldDetail
CompanyAni Pharmaceuticals Inc (ANIP)
Form Type10-Q
Filed DateMay 9, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, pharmaceuticals, filing

TL;DR

ANI Pharma filed its Q1 2025 10-Q. Details sparse, but it's an update.

AI Summary

ANI Pharmaceuticals Inc. reported its first quarter results for the period ending March 31, 2025. The company's filing indicates a fiscal year end of December 31, 2025. Key financial details and specific dollar amounts are not provided in this excerpt, but the filing pertains to their ongoing business operations.

Why It Matters

This 10-Q filing provides an update on ANI Pharmaceuticals' financial performance and business activities for the first quarter of 2025, which is crucial for investors to assess the company's current health and future prospects.

Risk Assessment

Risk Level: low — The provided excerpt is a standard 10-Q filing header and does not contain specific financial performance data or significant disclosures that would indicate a high-risk level.

Key Players & Entities

  • ANI PHARMACEUTICALS INC (company) — Filer
  • 20250331 (date) — Reporting Period End Date
  • 20250509 (date) — Filing Date
  • 210 MAIN STREET WEST (address) — Business Address
  • BAUDETTE (city) — Business Address City
  • MN (state) — Business Address State
  • 56623 (zip_code) — Business Address Zip
  • BIOSANTE PHARMACEUTICALS INC (company) — Former Company Name
  • BEN ABRAHAM TECHNOLOGIES INC (company) — Former Company Name

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is March 31, 2025.

When was this 10-Q filing submitted to the SEC?

This 10-Q filing was submitted on May 9, 2025.

What is the primary business address of ANI Pharmaceuticals Inc.?

The primary business address of ANI Pharmaceuticals Inc. is 210 Main Street West, Baudette, MN 56623.

What was ANI Pharmaceuticals Inc. previously known as?

ANI Pharmaceuticals Inc. was formerly known as BIOSANTE PHARMACEUTICALS INC and BEN ABRAHAM TECHNOLOGIES INC.

What is the Standard Industrial Classification code for ANI Pharmaceuticals Inc.?

The Standard Industrial Classification code for ANI Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding ANI PHARMACEUTICALS INC (ANIP).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.